Cadonilimab, CAS 2394841-59-7

Product Description: Cadonilimab (AK104) is a targeting PD1/CTLA4 IgG1 scaffold Fc-engineered humanized antibody. Cadonilimab can be used for researching metastatic cervical cancer[1][2].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Antonarelli G, et al. Research and Clinical Landscape of Bispecific Antibodies for the Treatment of Solid Malignancies. Pharmaceuticals (Basel). 2021 Aug 31;14(9):884./[2]Kaplon H, et al. Antibodies to watch in 2022. MAbs. 2022 Jan-Dec;14(1):2014296.

CAS Number: 2394841-59-7

Molecular Weight: N/A

Compound Purity: 99.29

Research Area: Cancer

Solubility: H2O

Target: PD-1/PD-L1

• Artikelnummer: MEXHY-P99117-1
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99117-1
• Green Labware: Nein
• Verpackungseinheit: 1 mg
• Mengeneinheit: STK